Coya Therapeutics, Inc. has announced a Securities Purchase Agreement of 603,136 shares at issue price of $8.29 per share for an aggregate gross proceeds of $4,999,997 on May 17, 2024. The transaction includes investor participation of new investor, Alzheimers Drug Discovery Foundation. The Shares issued to the ADDF under the Purchase Agreement were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D, which is promulgated under the Securities Act.